![Michael Tönes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Tönes
Directeur Général chez
BC Brandenburg Capital GmbH
Profil
Mr. Michael Tönes is a Managing Director at BC Brandenburg Capital GmbH.
Mr. Tönes was previously employed as Chairman-Supervisory Board by Combinature BioPharm AG and a Director-Supervisory Board by Capsulution Pharma AG.
Postes actifs de Michael Tönes
| Sociétés | Poste | Début |
|---|---|---|
BC Brandenburg Capital GmbH
 BC Brandenburg Capital GmbH Investment ManagersFinance BC GmbH is a regional venture capital and private equity investment firm who invests capital to support growth and innovation across development phases, including seed capital, R&D, market launch, growth financing and IPO preparation. The firm invests in small- to medium-sized companies, primarily in technology-related sectors. They invest in ICT, life sciences, nanotechnology, microelectronics, testing, metrology, industrial engineering and process engineering. BC GmbH invests in companies whose activity is related to the Brandenburg region. The firm targets businesses with a convincing entrepreneurial concept, clear growth perspectives, a product or technology with distinctive unique selling points, and a visible exit opportunity. They invest EUR 100 thousand to 5 million in direct equity, generally minority stakes, or as a silent partner, or in a combination of both. Their targeted exit horizon is four to eight years. Their exit strategies include buyback, trade sale, IPO and secondary sale. | Directeur Général | 01/01/2001 |
Anciens postes connus de Michael Tönes
| Sociétés | Poste | Fin |
|---|---|---|
Combinature BioPharm AG
 Combinature BioPharm AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Président | 27/08/2008 |
Capsulution Pharma AG
 Capsulution Pharma AG Miscellaneous Commercial ServicesCommercial Services Develops and provides nano and micronsized capsules | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Combinature BioPharm AG
Combinature BioPharm AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops drugs | Commercial Services |
Capsulution Pharma AG
Capsulution Pharma AG Miscellaneous Commercial ServicesCommercial Services Develops and provides nano and micronsized capsules | Commercial Services |
BC Brandenburg Capital GmbH
BC Brandenburg Capital GmbH Investment ManagersFinance BC GmbH is a regional venture capital and private equity investment firm who invests capital to support growth and innovation across development phases, including seed capital, R&D, market launch, growth financing and IPO preparation. The firm invests in small- to medium-sized companies, primarily in technology-related sectors. They invest in ICT, life sciences, nanotechnology, microelectronics, testing, metrology, industrial engineering and process engineering. BC GmbH invests in companies whose activity is related to the Brandenburg region. The firm targets businesses with a convincing entrepreneurial concept, clear growth perspectives, a product or technology with distinctive unique selling points, and a visible exit opportunity. They invest EUR 100 thousand to 5 million in direct equity, generally minority stakes, or as a silent partner, or in a combination of both. Their targeted exit horizon is four to eight years. Their exit strategies include buyback, trade sale, IPO and secondary sale. | Finance |
